When Patients Can’t Pay, Surgeons Steer Away From Expensive Robots, Study Finds

When a patient walks into a urology clinic facing prostate cancer surgery, the surgeon standing across from them holds enormous power over what happens next. They decide which operation to recommend, which technology to describe in glowing terms, and which trade-offs to emphasize. A new study from China suggests that this recommendation process may be quietly shaped by something few patients would ever suspect: the patient’s own ability to pay.

The research, published in BMC Health Services Research, used a rigorous survey technique known as a discrete choice experiment to probe how urologists weigh the pros and cons of two competing surgical options for prostate cancer: laparoscopic radical prostatectomy, a minimally invasive procedure performed with long-handled instruments and video guidance, and robot-assisted radical prostatectomy, a costlier alternative in which the surgeon controls articulated robotic arms from a console. Both operations aim to remove the cancerous prostate gland, but they differ in cost, in how quickly patients typically regain urinary control, and in how much physical and mental strain they place on the surgeon at the operating table.

The study’s central finding is striking. When researchers asked urologists to make choices on behalf of a hypothetical patient with ample financial resources, the doctors prioritized clinical outcomes above all else. Urinary continence recovery at three months after surgery carried the highest estimated relative importance among the five attributes examined, while the total surgical charge was not statistically significant at all. In other words, for a well-resourced patient, money simply did not enter the calculus in a measurable way. But when the identical exercise was repeated for a hypothetical patient facing financial constraints, the picture flipped completely: total surgical charge became the single most important factor driving the urologists’ stated choices.

This is not a trivial shift in emphasis. It points to what the researchers describe as a potential affordability-sensitive pathway operating at the recommendation stage of care. Most discussions of health inequity focus on whether patients can reach a hospital that owns the technology, or whether they agree to undergo an expensive procedure when it is offered. This study adds a third, less visible channel: clinicians themselves may adjust their recommendations depending on what they believe a patient can afford, effectively filtering access to high-cost technology before the patient ever gets a chance to decide.

The numbers behind the headline finding are equally revealing. The researchers constructed illustrative surgical profiles that combined differences in surgical charge, continence recovery, surgeon fatigue, and technology availability, and then used their statistical models to predict which option urologists would choose under each financial scenario. For the well-resourced patient, the predicted probability of choosing the robot-assisted profile was 86.2 percent. For the financially constrained patient, the predicted probability of choosing the less expensive laparoscopic profile was 85.9 percent. Two nearly mirror-image probabilities, generated by nothing more than a change in the patient’s presumed financial situation, capture the scale of the effect with unusual clarity.

The methodology deserves attention because it is one of the more powerful tools available for studying decisions that cannot easily be observed in the real world. In a discrete choice experiment, respondents are presented with repeated pairs of hypothetical options, each described by the same set of attributes but with different levels, and asked to choose between them. By varying the attribute levels systematically across many choice tasks and analyzing the patterns of choices with mixed logit models, researchers can estimate the implicit weight each decision-maker places on each attribute. The approach reveals preferences that surgeons themselves might not be able to articulate, and that would be nearly impossible to measure by simply watching clinics in action, where patient financial circumstances are entangled with countless other factors.

The scope of the survey lends the findings considerable weight. The analysis included 211 urologists drawn from 87 hospitals spanning 26 provinces across China, making it a genuinely national picture of the medical workforce that staffs robot-equipped public hospitals. Each respondent completed paired choice tasks under both patient financial scenarios, allowing the researchers to compare the same doctor’s stated preferences across the two conditions. This within-person design is important, because it means the dramatic shift in the importance of surgical charge cannot be explained away by differences between the kinds of doctors who happened to answer one version of the survey versus another.

The five attributes built into the experiment were chosen to reflect the real trade-offs of technology-intensive surgery. Urinary continence recovery at three months represents the clinical outcome that matters most to many men undergoing prostatectomy, since incontinence is one of the most feared complications of the operation. Total surgical charge captures the direct financial burden on the patient. Intraoperative surgeon fatigue reflects the physical and cognitive toll of the procedure on the clinician, which can differ substantially between long hours at a laparoscopic console and manipulating instruments manually. Surgical-system availability acknowledges the practical reality that a robot may or may not be free when a patient needs it. Additional incentives captured any extrinsic motivations that might nudge a surgeon toward one platform or the other.

Beyond the headline flip between scenarios, the study uncovered meaningful heterogeneity among the surgeons themselves. Urologists older than 35 years placed greater weight on reduced intraoperative fatigue, suggesting that experience, or perhaps the accumulated physical toll of years in the operating room, shapes how much a surgeon values technologies that make the operation easier on them. Sensitivity to surgical charge, meanwhile, varied across regions of China, hinting that local economic conditions, regional insurance arrangements, or differing hospital financing structures may condition how strongly cost considerations penetrate clinical decision-making. These patterns matter for policy, because they suggest that any intervention aimed at making high-cost technology access more equitable cannot be designed as a one-size-fits-all solution.

The implications reach well beyond Chinese urology. Robotic surgical systems have spread rapidly through hospitals worldwide, promising enhanced precision and dexterity but carrying price tags that can run into the millions of dollars for the equipment alone, before counting per-procedure disposable instruments and maintenance contracts. As health systems everywhere grapple with which technologies to buy and which patients should receive them, this study offers a reminder that the human beings in white coats are not neutral conduits of technological supply. Their recommendations are themselves a rationing mechanism, one that operates invisibly, without formal rules or oversight, and one that may respond to a patient’s wallet in ways neither the patient nor the clinician fully recognizes. Making that hidden pathway visible, the authors suggest, is a necessary first step toward ensuring that access to transformative surgical technology depends on medical need rather than financial circumstance.

Subject of Research: Urologists' preferences for high-cost robotic versus laparoscopic prostatectomy under different patient financial scenarios in China

Article Title: Urologists’ stated preferences for high-cost surgical technology under different patient financial scenarios: a discrete choice experiment in China

Article References: Zhang, J., Zhao, J., Dai, Y., Gu, Y., & Hu, M. (2026). Urologists’ stated preferences for high-cost surgical technology under different patient financial scenarios: a discrete choice experiment in China. BMC Health Services Research. https://doi.org/10.1186/s12913-026-15690-w

Image Credits: AI Generated

DOI: 10.1186/s12913-026-15690-w

Keywords: discrete choice experiment, urology, robotic surgery, prostate cancer, laparoscopic radical prostatectomy, robot-assisted radical prostatectomy, health equity, affordability, access to care, health services research, China, surgeon decision-making